-
-
-
-
-
-
-
Gyre Therapeutics receives CDE alignment on conditional approval pathway for Hydronidone
-
-
-
-
-
-
-
Gyre Therapeutics (GYRE) Offering 2.2M Shares at $9 Per
-
-
-
-
-
-
-
Gyre Therapeutics (GYRE) Appoints Ping Zhang to its Board
-
-
-
-
-
408,310 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

